PDII Lower on Expected Reductions from AstraZeneca

February 10, 2006 9:27 AM EST Send to a Friend
PDI, Inc. (Nasdaq: PDII) is under heavy pressure this morning (-16.8%) after the company disclosed it ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login